Premium
New TAVR item added to cart for large scale clinical testing
Author(s) -
Belardi Jorge A.,
Lamelas Pablo M.
Publication year - 2021
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.29855
Subject(s) - medicine , cart , valve replacement , clinical trial , leak , intensive care medicine , environmental engineering , mechanical engineering , stenosis , engineering
Key Points There is no single TAVR prosthesis that can be considered ideal for all patients, needing the development of newer technologies. The GENESIS trial tested 40 patients with the Hydra self‐expandable supra‐annular TAVR with promising results in terms of efficacy, paravalvular leak, and pacemaker risk. Future larger experimental trials are needed to better understand its non‐inferiority to prior technologies.